Search results
Results from the Tech24 Deals Content Network
In 1979, Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopedic implants market (Stryker). In 1999 annual sales reached $2.1 billion, and in 2000 Stryker was included in the S&P 500 and the Forbes Platinum 400 for the first time.
US$ -32.55Million (2012) [3] MAKO Surgical Corp. was a publicly traded medical device company based in Florida. On September 25, 2013, the Board of Directors of Mako Surgical accepted a deal to be acquired by Stryker for $1.65B. [4] [5] The deal closed in December 2013. Founded in 2004, the company manufactures and markets surgical robotic arm ...
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share ...
The joint-implant maker raised the lower end of its profit forecast to $10.35 from 10.25 per share, while keeping the top-end of the range unchanged at $10.45. The company also beat Wall Street ...
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises a concern.
This page was last edited on 21 March 2009, at 06:08 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
Chairman and CEO of Stryker Corp (NYSE:SYK) Kevin Lobo sold 41,750 shares of SYK on 03/25/2019 at an average price of $194.11 a share.
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthopedic devices giant Stryker (NYS: SYK) has earned a ...